ATE390147T1 - Photodynamische therapie mit verminderter bestrahlungsstärke - Google Patents

Photodynamische therapie mit verminderter bestrahlungsstärke

Info

Publication number
ATE390147T1
ATE390147T1 AT02711694T AT02711694T ATE390147T1 AT E390147 T1 ATE390147 T1 AT E390147T1 AT 02711694 T AT02711694 T AT 02711694T AT 02711694 T AT02711694 T AT 02711694T AT E390147 T1 ATE390147 T1 AT E390147T1
Authority
AT
Austria
Prior art keywords
photodynamic therapy
radiation power
reduced radiation
fluence rate
neovasculature
Prior art date
Application number
AT02711694T
Other languages
English (en)
Inventor
H Strong
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE390147T1 publication Critical patent/ATE390147T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
AT02711694T 2001-02-06 2002-02-06 Photodynamische therapie mit verminderter bestrahlungsstärke ATE390147T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26696001P 2001-02-06 2001-02-06

Publications (1)

Publication Number Publication Date
ATE390147T1 true ATE390147T1 (de) 2008-04-15

Family

ID=23016703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02711694T ATE390147T1 (de) 2001-02-06 2002-02-06 Photodynamische therapie mit verminderter bestrahlungsstärke

Country Status (8)

Country Link
US (2) US6800086B2 (de)
EP (1) EP1357946B1 (de)
AT (1) ATE390147T1 (de)
CA (1) CA2437557C (de)
DE (1) DE60225783T2 (de)
ES (1) ES2304429T3 (de)
PT (1) PT1357946E (de)
WO (1) WO2002062384A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE489050T1 (de) * 2000-02-11 2010-12-15 Gen Hospital Corp Photochemische gewebeverbindung
US7073510B2 (en) * 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
US7753943B2 (en) * 2001-02-06 2010-07-13 Qlt Inc. Reduced fluence rate PDT
US7060695B2 (en) 2001-02-06 2006-06-13 Qlt, Inc. Method to prevent vision loss
WO2002062384A2 (en) * 2001-02-06 2002-08-15 Qlt Inc. Reduced fluence rate pdt
US7303578B2 (en) * 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
US20050159793A1 (en) * 2002-07-02 2005-07-21 Jackson Streeter Methods for treating macular degeneration
FR2842413B1 (fr) * 2002-07-18 2005-06-03 Univ Lille Sciences Tech Appareil pour le traitement de la degenerescence maculaire liee a l'age (dmla)
US20040110731A1 (en) * 2002-12-04 2004-06-10 Chan Agnes H. Photodynamic therapy for the treatment of non-melanoma skin cancer
US7354432B2 (en) * 2003-01-17 2008-04-08 Mcw Research Foundation, Inc. Red to near-infrared photobiomodulation treatment of the visual system in visual system disease or injury
US20050059731A1 (en) * 2003-09-16 2005-03-17 Ceramoptec Industries, Inc. Erythrosin-based antimicrobial photodynamic therapy compound and its use
FR2864903B1 (fr) * 2004-01-14 2006-09-15 Optical System Res For Industr Appareil de traitement notamment par laser d'un cancer ou d'un etat precancereux
WO2006036176A1 (en) * 2004-09-24 2006-04-06 Light Sciences Corporation Extended treatment of tumors through vessel occlusion with light activated drugs
US20060084951A1 (en) * 2004-10-05 2006-04-20 Heacock Gregory L Low energy of excitation PDT compounds for treatment of ocular disease
EP1827417A4 (de) * 2004-12-15 2008-05-21 Light Sciences Oncology Inc Photodynamische therapie mit verbesserter okklusiver wirkung
US20060134004A1 (en) * 2004-12-21 2006-06-22 The University Of Utah Methods and apparatus for detection of carotenoids in macular tissue
US20060244913A1 (en) * 2004-12-21 2006-11-02 Werner Gellermann Imaging of macular pigment distributions
JP2008530235A (ja) * 2005-02-17 2008-08-07 ライト サイエンシーズ オンコロジー， インコーポレイテッド 光反応システムおよびアテローム性動脈硬化の予防的治療法
UA80467C2 (en) * 2005-08-31 2007-09-25 Leonid Andriiovych Lynnyk Method and device for treating macular dystrophy
US20070123844A1 (en) * 2005-10-19 2007-05-31 Shelly Henry Method for treating ocular disorders
HRP20060149B1 (en) * 2006-04-19 2008-11-30 Institut "Ruđer Bošković" Intelligent sequential illuminator photodynamic therapy
JP5346587B2 (ja) * 2006-11-30 2013-11-20 学校法人慶應義塾 光線力学的治療（ｐｄｔ）を利用した異常電気伝導遮断装置
US8785491B2 (en) * 2008-06-19 2014-07-22 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
JP5988584B2 (ja) 2008-12-16 2016-09-07 キュー エル ティー インク．ＱＬＴ Ｉｎｃ． 眼の状態に関する光線力学的療法
US10987126B2 (en) 2017-05-03 2021-04-27 Medtronic Vascular, Inc. Tissue-removing catheter with guidewire isolation liner
US11690645B2 (en) 2017-05-03 2023-07-04 Medtronic Vascular, Inc. Tissue-removing catheter
US11638833B2 (en) 2017-08-02 2023-05-02 Multi Radiance Medical Reducing light polution in photobiomodulation therapy of a patients eye
BR112020002313B1 (pt) 2017-08-02 2022-04-19 Multi Radiance Medical Sistema e método para direcionar luz ao olho de um paciente
US11819236B2 (en) 2019-05-17 2023-11-21 Medtronic Vascular, Inc. Tissue-removing catheter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
CA2536069C (en) 1994-03-14 2008-06-03 Massachusetts Eye And Ear Infirmary Use of green porphyrins in ocular diagnosis and therapy
US5756541A (en) 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
JP3613599B2 (ja) 1996-10-01 2005-01-26 ワイス株式会社 イミノクロリンアスパラギン酸誘導体
US6270749B1 (en) 1996-12-11 2001-08-07 Pharmacyclics, Inc. Use of Texaphyrin in ocular diagnosis and therapy
AU1617001A (en) * 1999-11-17 2001-05-30 Qlt Inc. Use of low-dose pdt to inhibit restenosis
AU2001234979B2 (en) 2000-02-10 2006-07-27 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
US6524330B1 (en) * 2000-10-27 2003-02-25 Bahram Khoobehi Method of ocular treatment
WO2002062386A2 (en) * 2001-02-06 2002-08-15 Qlt Inc. Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
WO2002062384A2 (en) * 2001-02-06 2002-08-15 Qlt Inc. Reduced fluence rate pdt

Also Published As

Publication number Publication date
CA2437557C (en) 2012-07-24
CA2437557A1 (en) 2002-08-15
US20020173832A1 (en) 2002-11-21
US20050070518A1 (en) 2005-03-31
PT1357946E (pt) 2008-06-27
ES2304429T3 (es) 2008-10-16
WO2002062384A3 (en) 2003-05-15
EP1357946A2 (de) 2003-11-05
DE60225783T2 (de) 2009-04-09
EP1357946B1 (de) 2008-03-26
DE60225783D1 (de) 2008-05-08
US6800086B2 (en) 2004-10-05
WO2002062384A2 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
ATE390147T1 (de) Photodynamische therapie mit verminderter bestrahlungsstärke
WO2002096366A3 (en) Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
US20100222852A1 (en) Apparatus and Method for Decolonizing Microbes on the Surfaces of the Skin and In Body Cavities
DE60336086D1 (en) Photodynamisches therapiegerät
ATE328642T1 (de) Phototherapeutische systeme
GB2382991A8 (en) Photo-dynamic therapy device using organic semiconductor light emitters and reduced photo-pharmaceutical bleaching
NZ332862A (en) Balloon catheter for photoactive therapy with extended irradiation window
AR037307A1 (es) Metodos para el tratamiento de enfermedades oculares neovasculares
ATE526989T1 (de) Photodynamische therapie mit chemolumineszenz und ligand-photosensibilisator-konjugat
AU2003249807A1 (en) Combined photocoagulation and photodynamic therapy
WO2018090840A1 (zh) 一种应用于代谢性疾病的光治疗装置及方法
Chang et al. In vitro and in vivo efficacy of new blue light emitting diode phototherapy compared to conventional halogen quartz phototherapy for neonatal jaundice
RU2012110193A (ru) Устройство для облучения актиничным излучением с разными длинами волн
CN103610464A (zh) 一种使用led对口腔牙周炎进行光动力治疗的方法及其装置
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
Menezes et al. Photodynamic therapy for Photogem® and Photofrin® using different light wavelengths in 375 human melanoma cells
WO2006041744A3 (en) Low energy pdt for ocular disease
MXPA04007443A (es) Nuevos compuestos de porfirina-platino solubles en agua con alta selectividad tumoral y su uso para el tratamiento de enfermedades tumorales benignas y malignas.
WO2005048944A3 (en) Activatable photodynamic therapy agents
US20230045570A1 (en) Light radiation device for medical treatment
EP1550449A4 (de) Antitumorale mittel mit hsv
WO2003018006A1 (fr) Complexe porphyrine-oxyde de zinc et son utilisation comme medicament photosensible stimulant l'activite photodynamique par rayonnement, et utilisation correspondante dans un traitement cible
WO1997040888A1 (en) Therapy apparatus and method
KR20070002794A (ko) 광선치료기
RU96007U1 (ru) Устройство для облучения поверхности тела оптическим излучением при ожогах

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1357946

Country of ref document: EP